Metastatic angiosarcoma is one of the most challenging forms of a rare and aggressive cancer that develops in the cells lining blood vessels and lymph vessels. When angiosarcoma spreads beyond its original location to distant parts of the body, patients face an extremely difficult journey with limited survival time and complex treatment decisions ahead.

Understanding Metastatic Angiosarcoma

Metastatic angiosarcoma occurs when this already rare cancer spreads from its original site to other organs or tissues in the body. Angiosarcoma is a malignant tumor that originates from endothelial cells, which are the cells that form the inner lining of blood vessels and lymph vessels throughout the body. These cells normally create a barrier between the bloodstream and surrounding tissues, but in angiosarcoma, they become cancerous and multiply uncontrollably.^[1]

This cancer is known for being particularly aggressive. It infiltrates surrounding tissues easily and has a high tendency to recur locally even after treatment. More concerning is its strong propensity for metastasis, meaning the cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to establish new tumors in distant parts of the body.^[1]

When angiosarcoma spreads, it most commonly affects the lungs, liver, bones, and brain. Among patients diagnosed with metastatic disease, the lungs are the most frequent site of spread, with about 60% of metastatic cases involving lung tissue. The liver is affected in approximately 30% of cases, bones in about 43%, and the brain in roughly 9% of patients. Many patients develop metastases in multiple sites simultaneously, with about one-third having two or more locations affected at the same time.^[4]

How Common Is Metastatic Angiosarcoma

Angiosarcoma itself is exceptionally rare, accounting for only 1 to 2% of all soft tissue sarcomas. Since soft tissue sarcomas themselves are uncommon cancers, this makes angiosarcoma extremely unusual. The disease affects approximately one person per million population each year in the United States.^[1]

What makes the situation more alarming is how frequently angiosarcoma presents with advanced disease. Between 16% and 44% of all angiosarcoma patients already have metastatic disease at the time of their initial diagnosis. This means that nearly half of all patients discover the cancer only after it has already spread beyond the original location.^[1][8]

The disease can affect anyone at any age, but it is more commonly diagnosed in elderly patients, with a median age at diagnosis ranging from 52 to 67 years across different studies. While angiosarcoma affects men and women equally overall, certain types show gender preferences. For instance, angiosarcoma of the head and neck occurs twice as frequently in men as in women, and it particularly affects elderly white men.^[1][8]

What Causes Angiosarcoma and Its Spread

The exact cause of most angiosarcomas remains unknown. In many cases, the cancer appears spontaneously without any identifiable trigger. However, researchers have identified several important risk factors that increase the likelihood of developing this disease.^[1]

Previous radiation therapy is one of the most significant risk factors. Angiosarcoma can develop as a secondary cancer years after a patient receives radiation treatment for another cancer, most commonly breast cancer. These radiation-induced angiosarcomas typically appear approximately eight to ten years after the initial radiation therapy. While the risk is elevated for those who received radiation, the actual incidence remains low, with less than 1% of radiation patients eventually developing angiosarcoma.^[1][9]

Chronic lymphedema is another well-established risk factor. Lymphedema is prolonged swelling caused by accumulation of lymphatic fluid in tissues. This condition most commonly develops after radical mastectomy for breast cancer, but it can also result from other surgeries, infections, or congenital conditions. When angiosarcoma develops in the setting of chronic lymphedema, it is sometimes called Stewart-Treves syndrome.^[1][9]

Exposure to certain chemicals has been linked to angiosarcoma development, particularly in the liver. Occupational exposure to vinyl chloride, arsenic, thorium dioxide, and radium has been associated with this cancer. These chemical-related angiosarcomas may not appear until 10 to 40 years after the initial exposure.^[1]

Recent research has also identified excessive ultraviolet radiation from prolonged sun exposure as a potential risk factor. This may explain why cutaneous angiosarcomas occur more commonly on the face and scalp of elderly individuals, particularly Caucasian men who have had significant sun exposure throughout their lives.^[8]

Risk Factors for Developing Metastatic Disease

Once angiosarcoma develops, certain characteristics increase the risk that it will spread to distant sites. The size of the primary tumor is a critical factor. Tumors larger than 10 centimeters have a significantly worse prognosis and are more likely to metastasize compared to smaller tumors. Studies have shown that tumor size is an independent predictor of both overall survival and cancer-specific survival in metastatic cases.^[4]

The grade of the tumor also matters. Tumor grade refers to how abnormal the cancer cells look under a microscope and how quickly they are likely to grow and spread. Grade IV angiosarcomas, which represent the most abnormal and aggressive cells, are associated with worse outcomes and higher rates of metastasis.^[4]

The location of the original tumor influences prognosis as well. Angiosarcomas that develop in certain sites, such as the head and neck, tend to behave more aggressively than those in other locations. The highly vascular nature of the scalp and face may contribute to easier spread of cancer cells through blood vessels.^[1]

Age at diagnosis plays a role in outcomes. Older patients generally have worse survival rates compared to younger patients, though this may reflect both the biology of the disease and the overall health status of elderly individuals who may have difficulty tolerating aggressive treatments.^[4]

Symptoms of Metastatic Angiosarcoma

The symptoms of metastatic angiosarcoma vary greatly depending on where the cancer has spread. When the primary tumor is on the skin, patients may notice a rapidly growing lump or bump beneath the skin surface. The affected area may appear bruised or discolored, often with reddish or purple coloring. Unlike a normal bruise, this discoloration does not fade with time; instead, it may expand and grow larger. The lesion may bleed easily when scratched or bumped, and swelling may develop in the surrounding skin.^[2]

When angiosarcoma spreads to the lungs, patients may experience shortness of breath, persistent cough, or chest pain. Lung metastases can appear on imaging as characteristic cystic nodules surrounded by ground-glass changes, which helps radiologists identify them as likely metastatic angiosarcoma.^[8]

Liver metastases may cause abdominal pain, particularly in the upper portion of the abdomen. Patients may experience fatigue, unexplained weight loss, and jaundice, which is a yellowing of the skin and eyes caused by liver dysfunction.^[5]

When angiosarcoma spreads to bones, patients typically experience pain in the affected area. This pain may worsen over time and can become severe, especially at night or with activity. Bone metastases can weaken the bone structure, increasing the risk of fractures.^[4]

Brain metastases can cause headaches, seizures, changes in vision, difficulty with balance or coordination, personality changes, or other neurological symptoms depending on which part of the brain is affected.^[4]

Many patients with metastatic angiosarcoma experience general symptoms that reflect the widespread nature of their disease. These include profound fatigue, unintentional weight loss, loss of appetite, and a general feeling of being unwell, which doctors call malaise.^[9]

Prevention and Early Detection

Because the exact cause of most angiosarcomas remains unknown, specific prevention strategies are limited. However, understanding risk factors can help with early detection and potentially catch the disease before it spreads.

People who have received radiation therapy for previous cancers should remain vigilant for any unusual skin changes in the radiated area, particularly if several years have passed since treatment. Any new, persistent, or growing lesions should be evaluated promptly by a healthcare provider. Regular follow-up appointments with oncologists can help monitor for late effects of radiation treatment.^[1]

Individuals with chronic lymphedema should carefully monitor the affected limb for any changes in skin appearance or texture. New lesions, discoloration, or non-healing wounds should be examined by a doctor without delay. Proper management of lymphedema through compression garments, elevation, and specialized therapy may help reduce risk, though this has not been definitively proven.^[1]

For those with occupational exposure to chemicals known to increase angiosarcoma risk, following workplace safety protocols and using appropriate protective equipment is essential. Regular medical surveillance programs in high-risk industries can help detect problems early.^[1]

Sun protection may help reduce risk of cutaneous angiosarcoma, particularly for elderly individuals. Using sunscreen, wearing protective clothing and hats, and avoiding excessive sun exposure during peak hours are sensible precautions, though their specific effectiveness against angiosarcoma has not been established.^[8]

For people diagnosed with localized angiosarcoma, aggressive initial treatment and close monitoring are crucial to detect any recurrence or metastasis as early as possible. Regular imaging studies and clinical examinations in the years following treatment can help identify metastatic disease when it is still potentially treatable.^[1]

How Metastatic Angiosarcoma Affects the Body

Understanding the physical changes that occur with metastatic angiosarcoma helps explain why this disease is so serious. At the cellular level, angiosarcoma cells have lost the normal controls that regulate cell growth and death. While healthy cells follow an orderly cycle of growth, division, and eventual death, cancer cells continue to multiply indefinitely. They form new, abnormal blood vessels that supply nutrients to the growing tumor.^[5]

These malignant cells have the dangerous ability to invade surrounding tissues. They produce enzymes that break down the normal tissue architecture, allowing them to spread locally and infiltrate nearby structures. This infiltrative growth pattern makes it extremely difficult to remove all cancer cells surgically, as microscopic extensions may reach far beyond the visible tumor margins.^[1]

The high rate of metastasis in angiosarcoma reflects the cancer’s vascular origin. Because the tumor cells arise from blood vessel lining cells, they have inherent properties that facilitate their entry into the bloodstream. Once in circulation, these cells can travel throughout the body and establish new tumors wherever they lodge. The cells may also spread through the lymphatic system, traveling from lymph node to lymph node.^[5]

When angiosarcoma cells establish metastatic tumors in vital organs like the lungs or liver, they interfere with normal organ function. In the lungs, multiple tumors can impair gas exchange, making it difficult for patients to get enough oxygen. Liver metastases can disrupt the liver’s critical functions in metabolism, detoxification, and protein production. Bone metastases weaken the skeletal structure and can cause debilitating pain.^[5]

The cancer also affects the body systemically. Tumor cells release substances that can cause fever, weight loss, and fatigue. The body’s immune system becomes activated trying to fight the cancer, but this inflammatory response often causes additional symptoms without successfully controlling the disease. The overall burden of widespread metastatic disease strains the body’s resources and gradually leads to organ failure.^[1]

Prognosis and Survival Rates

The outlook for patients with metastatic angiosarcoma is unfortunately very poor. Survival statistics paint a sobering picture of this aggressive disease. For patients who present with metastatic angiosarcoma at diagnosis, the median overall survival ranges from only 6 to 16 months. This means that half of patients live less than this time, while half live longer.^[1]

A large study examining 284 patients with metastatic angiosarcoma found that the one-year overall survival rate was just 20.8%, meaning only about one in five patients survived for a full year. By three years, the survival rate dropped to a mere 3.8%. The cancer-specific survival rates were similarly dismal, at 22% for one year and 5.2% for three years.^[4]

These statistics are dramatically worse than for localized angiosarcoma. Patients whose disease is caught before it spreads have a median overall survival of about 20 months, significantly better than those with metastatic disease at presentation, though still quite poor compared to many other cancers.^[4]

Several factors influence survival within the metastatic population. Patients who receive chemotherapy have better outcomes than those who do not, with chemotherapy being identified as an independent favorable predictor of survival. Radiation therapy also appears to provide survival benefit in certain situations. Younger patients generally survive longer than older patients. Smaller tumor size at diagnosis correlates with better outcomes, as does lower tumor grade.^[4]

The number and location of metastatic sites also matter. Patients with metastases in multiple organs face worse prognosis than those with disease limited to a single distant site. The specific organs involved influence outcomes as well, though all metastatic disease carries a grave prognosis regardless of location.^[4]